company background image
SBS logo

Stratec XTRA:SBS 株式レポート

最終価格

€28.85

時価総額

€350.7m

7D

-10.1%

1Y

-35.7%

更新

18 Nov, 2024

データ

会社財務 +

Stratec SE

XTRA:SBS 株式レポート

時価総額:€350.7m

SBS 株式概要

ストラテックSEは、その子会社とともに、ドイツ、欧州連合、および国際的に、体外診断およびライフサイエンス分野におけるオートメーションおよび計装ソリューションの設計・製造を行っている。 詳細

SBS ファンダメンタル分析
スノーフレーク・スコア
評価3/6
将来の成長4/6
過去の実績1/6
財務の健全性4/6
配当金4/6

Stratec SE 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめStratec
過去の株価
現在の株価€28.85
52週高値€48.60
52週安値€28.40
ベータ0.23
11ヶ月の変化-30.23%
3ヶ月変化-34.06%
1年変化-35.75%
33年間の変化-79.42%
5年間の変化-56.29%
IPOからの変化454.49%

最新ニュース

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Nov 09
With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Oct 26
Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Recent updates

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Nov 09
With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Oct 26
Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

May 11
Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Apr 11
Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Apr 01
Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Mar 28
Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Dec 21
Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 03
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Oct 19
We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Return Trends At Stratec (ETR:SBS) Aren't Appealing

Jul 12
Return Trends At Stratec (ETR:SBS) Aren't Appealing

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 27
Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Is Stratec (ETR:SBS) Using Too Much Debt?

May 25
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

Apr 02
Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

The Returns At Stratec (ETR:SBS) Aren't Growing

Jan 28
The Returns At Stratec (ETR:SBS) Aren't Growing

Calculating The Fair Value Of Stratec SE (ETR:SBS)

Jan 12
Calculating The Fair Value Of Stratec SE (ETR:SBS)

Is Stratec (ETR:SBS) A Risky Investment?

Oct 26
Is Stratec (ETR:SBS) A Risky Investment?

Returns On Capital At Stratec (ETR:SBS) Have Stalled

Oct 11
Returns On Capital At Stratec (ETR:SBS) Have Stalled

Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Jul 23
Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 07
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 12
Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Apr 28
Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Apr 03
Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

Apr 02
Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Mar 13
These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Feb 12
Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Jan 27
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Dec 05
We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 02
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Oct 18
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Is Stratec (ETR:SBS) Using Too Much Debt?

Sep 03
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Aug 03
Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 20
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Jun 14
Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

May 31
Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

株主還元

SBSDE Medical EquipmentDE 市場
7D-10.1%-3.7%-0.5%
1Y-35.7%-4.2%8.3%

業界別リターン: SBS過去 1 年間で-4.2 % の収益を上げたGerman Medical Equipment業界を下回りました。

リターン対市場: SBSは、過去 1 年間で8.3 % のリターンを上げたGerman市場を下回りました。

価格変動

Is SBS's price volatile compared to industry and market?
SBS volatility
SBS Average Weekly Movement4.9%
Medical Equipment Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.0%
10% least volatile stocks in DE Market2.4%

安定した株価: SBS過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: SBSの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19791,462Marcus Wolfingerwww.stratec.com

ストラテックSEは、その子会社とともに、ドイツ、欧州連合、および国際的に、体外診断およびライフサイエンス分野における自動化および計装ソリューションの設計・製造を行っている。臨床診断やバイオテクノロジーの顧客向けに自動分析システムを設計・製造し、診断や医療アプリケーション向けに複雑な消耗品を提供している。同社は以前はSTRATEC Biomedical AGとして知られていたが、2018年12月にStratec SEに社名を変更した。Stratec SEは1979年に設立され、ドイツのビルケンフェルトに本社を置いている。

Stratec SE 基礎のまとめ

Stratec の収益と売上を時価総額と比較するとどうか。
SBS 基礎統計学
時価総額€350.70m
収益(TTM)€10.01m
売上高(TTM)€250.54m

35.0x

PER(株価収益率

1.4x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
SBS 損益計算書(TTM)
収益€250.54m
売上原価€182.78m
売上総利益€67.75m
その他の費用€57.74m
収益€10.01m

直近の収益報告

Sep 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)0.82
グロス・マージン27.04%
純利益率4.00%
有利子負債/自己資本比率67.0%

SBS の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

1.9%

現在の配当利回り

67%

配当性向